1. Pharmacology of heart failure: From basic science to novel therapies
   Achim Lother et al, 2016, Pharmacology & Therapeutics CrossRef
2. Protective role of downregulated MLK3 in myocardial adaptation to chronic hypoxia
   Siyi He et al, 2016, Journal of Physiology and Biochemistry CrossRef
3. Anti-TNF effect of combined pravastatin and cilostazol treatment in an in vivo mouse model
   Hae-Ri Lee et al, 2019, Immunopharmacology and Immunotoxicology CrossRef
4. G protein, phosphorylated-GATA4 and VEGF expression in the hearts of transgenic mice overexpressing β1- and β2-adrenergic receptors
   Hyun-Jin Tae et al, 2017, Molecular Medicine Reports CrossRef
5. Sublytic C5b-9 Induces Glomerular Mesangial Cell Apoptosis through the Cascade Pathway of MEKK2–p38 MAPK–IRF-1–TRADD–Caspase 8 in Rat Thy-1 Nephritis
   Ganqian Zhu et al, 2017, The Journal of Immunology CrossRef
6. Inflammatory Modulation by Statins and Heart Failure
   Nicoletta Ronda et al, 2015, Inflammation in Heart Failure CrossRef
7. GLP-1 Receptor Activation Inhibits Palmitate-Induced Apoptosis via Ceramide in Human Cardiac Progenitor Cells
   Anna Leonardini et al, 2017, The Journal of Clinical Endocrinology & Metabolism CrossRef
8. Mitochondrial dysfunction in heart failure and its therapeutic implications
   Miaosen Liu et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
9. Mitochondrial dyshomeostasis in cardiac aging and related diseases
   JiaWan WANG et al, 2024, SCIENTIA SINICA Vitae CrossRef
10. Mechanisms underlying direct actions of hyperlipidemia on myocardium: an updated review
    Yu Si Yao et al, 2020, Lipids in Health and Disease CrossRef
11. Mitochondrial unfolded protein response: An emerging pathway in human diseases
    Li Zhu et al, 2021, Free Radical Biology and Medicine CrossRef